This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A Third look: Discuss the standard of care and the launch bempedoic acid (NEXLETOL) and the CVOT outcome studies from Esperion in treating patients with atherosclerotic cardiovascular disease (ASCVD).

Ticker(s): ESPR

Who's the expert?

Sandeep Krishnan, MD, FACC, FSCAI completed his fellowship in interventional cardiology and structural/valvular heart disease at the University of Washington School of Medicine in Seattle, WA. He graduated summa cum laude from the University of Missouri-Kansas City School of Medicine and graduated with distinction from internal medicine residency at Emory University School of Medicine. He completed a cardiovascular diseases fellowship at the prestigious third-ranked Cedars-Sinai Heart Institute where he was selected for the coveted and highly prestigious ACC/Merck fellowship awarded to only four cardiology fellows across the country for fellow-initiated research in 2016. The fellowship provides grant money of $70,000 to support a fellow-initiated research project. Sandeep performed cutting edge work examining the relationship of vulnerable coronary plaque features to cardiac computed tomography findings. Dr. Krishnan has held several leadership positions in medical education at all levels including serving on the ACGME Board of Directors as a resident member in 2016-2018 and serving on the National Resident Matching Program Board of Directors as a medical student member from 2007 to 2009. Additionally, Krishnan serves in various leadership positions within the American College of Cardiology including serving on the Health Affairs Committee, the Board of Trustees Medical Malpractice Working Group, and the PAC Advisory Council. He has been recognized as a future leader of the college and was part of the ACC’s Leadership Academy and Emerging Advocates cohorts. Sandeep has also remained active in the AMA throughout his career and was most recently chairman of the Committee of Business and Economics in 2015-2016. He currently serves as the Director for Structural Heart Disease and the Director of Heart Failure Programs at King’s Daughters Medical Center in Ashland, KY. In his role, he has led the programs to tremendous growth in the past twelve months by doubling the TAVR volume and modernizing the program, while also starting MitraClip and Watchman programs simultaneously. He has reinvigorated the Cardiomems program and increased its volume by over 400%. When he is not busy with work, Sandeep enjoys rock climbing, playing the piano, and swimming. He is a voracious reader and accomplished technical writer as well. 

Interview Goal
Getting the experience of a clinician in treating patients with atherosclerotic cardiovascular disease (ASCVD).

Do you want answers to these questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.